Literature DB >> 11966956

Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature.

Koichi Tsuneyama1, Kenichi Harada, Kazuyoshi Katayanagi, Kishichiro Watanabe, Hiroshi Kurumaya, Hiroshi Minato, Yasuni Nakanuma.   

Abstract

Idiopathic portal hypertension (IPH) is characterized by dense fibrosis of portal tracts and portal venous obliteration. Little is known about the etiopathogenesis of IPH. Association of various autoimmune diseases such as systemic lupus erythematosus in IPH suggests that IPH may share immunological disturbances with such autoimmune diseases. We recently experienced two autopsy cases presenting with both diffuse scleroderma and IPH. Dense fibrosis was found in both the dermis and intrahepatic portal tract of these cases. In addition, small vascular damages were commonly observed to various degrees in these fibrotic areas of both organs. The activation of fibroblasts and vascular damages mediated by various growth factors and cytokines reportedly involved in the dermis in scleroderma might have also been operative in portal tracts in these two cases of IPH. A review of literature disclosed eight overlapping cases of IPH and scleroderma (middle- to old-aged females), and scleroderma was diagnosed earlier than IPH. These findings suggest that similar pathogenetic processes are operative in the dermis as well as in the portal tracts of the liver in these cases.

Entities:  

Mesh:

Year:  2002        PMID: 11966956     DOI: 10.1046/j.1440-1746.2002.02587.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  15 in total

1.  Induction of elastin expression in vascular endothelial cells relates to hepatoportal sclerosis in idiopathic portal hypertension: possible link to serum anti-endothelial cell antibodies.

Authors:  Y Sato; X S Ren; K Harada; M Sasaki; H Morikawa; S Shiomi; M Honda; S Kaneko; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 2.  Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.

Authors:  Ashish Goel; Joshua E Elias; Chundamannil E Eapen; Banumathi Ramakrishna; Elwyn Elias
Journal:  J Clin Exp Hepatol       Date:  2014-07-28

Review 3.  The current clinical aspects of idiopathic portal hypertension.

Authors:  Tomohiro Tanaka; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

4.  Idiopathic portal hypertension presenting with hepatic nodular regenerative hyperplasia after splenectomy: a case report.

Authors:  Yan Ren; Hui Liu; Wen-Yan Song; Ai-Qin Hao; Lu Li; Shuang Liu; Yu Chen; Zhong-Ping Duan; Su-Jun Zheng
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

5.  Idiopathic portal hypertension associated with systemic sclerosis and Sjögren's syndrome.

Authors:  Hiroyuki Kogawa; Kiyoshi Migita; Masahiro Ito; Yasushi Takii; Manabu Daikoku; Mikiko Nakao; Taichiro Miyashita; Hironori Kimura; Hironori Ezaki; Minoru Nakamura; Hiroshi Yatsuhashi; Katsumi Eguchi; Hiromi Ishibashi
Journal:  Clin Rheumatol       Date:  2005-05-05       Impact factor: 2.980

6.  Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension.

Authors:  Azusa Kitao; Yasunori Sato; Seiko Sawada-Kitamura; Kenichi Harada; Motoko Sasaki; Hiroyasu Morikawa; Susumu Shiomi; Masao Honda; Osamu Matsui; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

7.  Life-threatening hypersplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature.

Authors:  Jan Däbritz; Jennifer Worch; Ulrike Materna; Bernward Koch; Gabriele Koehler; Christina Duck; Michael C Frühwald; Dirk Foell
Journal:  BMC Gastroenterol       Date:  2010-10-20       Impact factor: 3.067

8.  Fifteen-year experience of pediatric-onset mixed connective tissue disease.

Authors:  Yi-Ying Tsai; Yao-Hsu Yang; Hsin-Hui Yu; Li-Chieh Wang; Jyh-Hong Lee; Bor-Luen Chiang
Journal:  Clin Rheumatol       Date:  2009-09-16       Impact factor: 2.980

Review 9.  Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data.

Authors:  Michel Kmeid; Xiuli Liu; Samuel Ballentine; Hwajeong Lee
Journal:  Gastroenterology Res       Date:  2021-04-21

Review 10.  Liver involvement in subjects with rheumatic disease.

Authors:  Carlo Selmi; Maria De Santis; M Eric Gershwin
Journal:  Arthritis Res Ther       Date:  2011-06-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.